Latest Expert Opinions

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
February 2, 2018

(A Top Pick March 13/17. Up 20%.) ROIC 15%+ for 20 years and now 20%. A technology play backed by the U.S. government. Valuation good plus decent dividend. This is a classic return on invested capital.

(A Top Pick March 13/17. Up 20%.) ROIC 15%+ for 20 years and now 20%. A technology play backed by the U.S. government. Valuation good plus decent dividend. This is a classic return on invested capital.

Matt Kacur
President, FSA Financial Science and Art
Price
$221.720
Owned
Unknown
BUY
BUY
February 2, 2018

Cleaned up their balance sheet. Still have a lot of debt though they've reigned it in. ROIC went from -8% to 3% in just two years. They're doing the right things.

Barrick Gold (ABX-T)
February 2, 2018

Cleaned up their balance sheet. Still have a lot of debt though they've reigned it in. ROIC went from -8% to 3% in just two years. They're doing the right things.

Matt Kacur
President, FSA Financial Science and Art
Price
$17.040
Owned
Unknown
BUY
BUY
February 2, 2018

Issues about competition with its drugs. Earns 26% ROIC, EBITDA has come down. In a good area, including oncology and HIV. A good pipeline, cash flow and valuations. Likes it a lot.

Issues about competition with its drugs. Earns 26% ROIC, EBITDA has come down. In a good area, including oncology and HIV. A good pipeline, cash flow and valuations. Likes it a lot.

Matt Kacur
President, FSA Financial Science and Art
Price
$81.730
Owned
Yes
SELL
SELL
February 2, 2018

A great company, but pause on the utilities space for now given rising interest rates. Now's a good time to sell then buy cheaper later for all utilities.

Enbridge (ENB-T)
February 2, 2018

A great company, but pause on the utilities space for now given rising interest rates. Now's a good time to sell then buy cheaper later for all utilities.

Matt Kacur
President, FSA Financial Science and Art
Price
$43.110
Owned
Unknown
DON'T BUY
DON'T BUY
February 2, 2018

Likes golds, but Eldorado's ROIC negative and still lags compared to everyone else in this space. There should be positive returns at this point in the cycle.

Eldorado Gold (ELD-T)
February 2, 2018

Likes golds, but Eldorado's ROIC negative and still lags compared to everyone else in this space. There should be positive returns at this point in the cycle.

Matt Kacur
President, FSA Financial Science and Art
Price
$1.510
Owned
Unknown
BUY
BUY
February 2, 2018

A lot of pressure from Amazon getting into CVS' space, but confident CVS will emerge well. CVS will fight back. But don't get too speculative on events (Amazon) that could happen. ROIC consistent. Good valuation. He has faith in CVS.

CVS Health Corp (CVS-N)
February 2, 2018

A lot of pressure from Amazon getting into CVS' space, but confident CVS will emerge well. CVS will fight back. But don't get too speculative on events (Amazon) that could happen. ROIC consistent. Good valuation. He has faith in CVS.

Matt Kacur
President, FSA Financial Science and Art
Price
$76.450
Owned
Unknown
DON'T BUY
DON'T BUY
February 2, 2018

His least favourite FANG. Prefers Amazon and Facebook. ROIC was 29% in 2012 at peak, but now 13%. How long can they milk the iPhone? Victim of their own success. They have so much cash sitting overseas. Will they invest it? Repurchase shares and pay a dividend would be his suggestion.

Apple (AAPL-Q)
February 2, 2018

His least favourite FANG. Prefers Amazon and Facebook. ROIC was 29% in 2012 at peak, but now 13%. How long can they milk the iPhone? Victim of their own success. They have so much cash sitting overseas. Will they invest it? Repurchase shares and pay a dividend would be his suggestion.

Matt Kacur
President, FSA Financial Science and Art
Price
$160.500
Owned
Unknown